PDE4A and Sepsis: In a recent review by Mokra et al., various PDE3, PDE4, and PDE5 inhibitors were reported to stabilize the pulmonary epithelial-endothelial barrier and reduce sepsis- and inflammation-increased microvascular permeability (Mokra and Mokry, 2021).